DNA RNA and Cells
23 June 2014
Regado Biosciences’ REG2 Demonstrates Dose and Concentration-Dependent Suppression of Thrombin Generation20 June 2014
Success in Kadimastem’s First Pre-Clinical Trial for Treatment of Amyotrophic Lateral Sclerosis (ALS)10 June 2014
Isis Pharmaceuticals Earns $15 Million from AstraZeneca for Initiation of Phase 1 Study of ISIS-AR Rx9 June 2014
Isis Pharmaceuticals Initiates Phase 1 Study of ISIS-DMPK Rx to Treat Myotonic Dystrophy Type 17 June 2014
First Patient Enrolled in BrainStorm’s Phase II ALS Trial at Massachusetts General Hospital5 June 2014
Medgenics Announces First Patient Implanted in Phase 1/2 Clinical Trial of MDGN-201 (EPODURE)3 June 2014
Prosensa Announces Regulatory Path Forward for Drisapersen as a Potential Treatment for DMDNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports